ARCHIVES

IOM Recommends FDA Consolidate Each Drug’s Lifetime History

This article is from The Cancer Letter archive.

Vol. 38 No. 18 | May 4, 2012

Download PDF Visit The Full Archive

Related Articles

Fake Avastin, Paid for by Medicare, Administered to U.S. Patients

October 3, 2014

Study Identifies Risk Factors To Predict Contralateral Cancer

February 27, 2009

NIH To Fund Fewer Grants This Year, But Reduce Cuts to Individual Awards.

February 8, 2008

Pathology Review Confirms Reserpine As Carcinogen

March 14, 1980

FASEB Calls For 15% Increase For NIH Next Fiscal Year.

January 26, 2001

NCI To Fund Partnerships Between Cancer Centers and Minority Institutions

November 12, 1999